Niagen Bioscience, Inc. (NAGE) vs Molson Coors Beverage Company (TAP-A)
The same free fields, in the same order, for both companies, so a figure on one line can be read straight across.
This page states measurements and nothing else. It does not rank the two companies, name one of them, or draw a conclusion from the figures.
Data as of Oct 27, 2026, for both companies.
The figures, field by field
A dash means the snapshot carries no figure for that company on that line. A line is dropped only when neither company has it, so a dash beside a figure is a fact about coverage, not about either company.
| NAGE | TAP-A | |
|---|---|---|
| Sector | Consumer Defensive | Consumer Defensive |
| Industry | Packaged Foods | Beverages - Brewers |
| Size band | SMALL | MID |
| Listing | Nasdaq CM | NYSE |
| Country | United States | United States |
| Theme | beauty-and-personal-care | alcoholic-beverages |
| Price and returns | ||
| Last close | $2.44 | $42.40 |
| Return · 1 week | −2.40% | +7.29% |
| Return · 1 month | −18.12% | +7.29% |
| Return · 3 months | −25.84% | +0.95% |
| Return · year to date | −60.96% | −7.98% |
| Return · 1 year | −67.89% | −5.98% |
| Distance from the 52-week highThe last close measured against the highest close of the past 52 weeks. | −69.31% | −24.18% |
| 52-week high | $7.95 | $55.92 |
| 52-week low | $2.39 | $39.51 |
| Size and turnover | ||
| Market value · USDConverted to US dollars, so two companies listed in different currencies sit under one heading. | $194.33M | $7.91B |
| Turnover · median day, USDThe median value traded in a session over the past 50 sessions. | $1.01M | — |
| Employees | 117 | 16,200 |
| Valuation | ||
| Price to earnings · trailing | 13.11× | n/a (negative earnings) |
| Price to earnings · forward | n/a (negative forward earnings) | — |
| Price to sales | 1.54× | 0.75× |
| Price to book | 2.39× | 0.82× |
| Enterprise value to EBITDA | 13.89× | 6.35× |
| Enterprise value to revenue | 1.03× | 1.30× |
| PEG ratio | — | 4.16 |
| Earnings per share · trailing | 0.19 | -11.64 |
| Profitability | ||
| Gross margin | 64.24% | 37.01% |
| Operating margin | 2.35% | 11.30% |
| Profit margin | 12.39% | −20.81% |
| Return on equity | 21.80% | −19.47% |
| Return on assets | 5.44% | 3.79% |
| Growth | ||
| Revenue growth | −4.30% | −3.30% |
| Earnings growth | −75.00% | −42.30% |
| Balance sheet and payout | ||
| Debt / equity (%) | 2.82 | 76.03 |
| Current ratio | 6.50 | 0.88 |
| Dividend yield | 0.00% | 4.32% |
| Payout ratio | 0.00% | 35.97% |
| Trend and volatility | ||
| RSI · 14 | 31.20 | 62.81 |
| ADX · 14 | 44.04 | 51.27 |
| 50-day average | $2.91 | $42.22 |
| 200-day average | $4.00 | $45.74 |
| Average true range · share of priceAverage true range over 14 sessions, stated as a share of the last close, so it can be read across two share prices. | 3.50% | 2.37% |
The full NAGE analysis
Everything this table leaves out for Niagen Bioscience, Inc.: the plain-language summary and key points, the accumulation read, signal history, full fundamentals, market context, and the case each side of the NAGE argument makes.
$9.90 per stock, one time, 30 days of access.
Open the full NAGE analysisThe full TAP-A analysis
Everything this table leaves out for Molson Coors Beverage Company: the plain-language summary and key points, the accumulation read, signal history, full fundamentals, market context, and the case each side of the TAP-A argument makes.
$9.90 per stock, one time, 30 days of access.
Open the full TAP-A analysis